Clinical Trials on Cancer

Total 51511 results

Fore Biotherapeutics

Completed

NovellusDx Tissue Collection Protocol

Patients That Have Been Diagnosed With Colorectal Cancer | Patients Eligible for Tumor Biopsy

Israel
Tata Memorial Hospital

Unknown

Feasibility Study Of A Telephonic Questionnaire For Follow-Up Of Locally Advanced Cervical Cancer Patients

Cervical Cancer Stage IIIB | Treatment Outcome | Follow up | QUESTIONNAIRE
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI); Fox Chase Cancer Center

Completed

Couples Therapy to Enhance Intimacy Between Patients With Advanced or Recurrent Prostate Cancer and Their Partners

Sexual Dysfunction | Prostate Cancer | Psychosocial Effects of Cancer and Its Treatment | Sexuality and Reproductive Issues

United States
Centre Oscar Lambret
National Cancer Institute, France; Centre Régional de Référence en Cancérologie

Completed

Alcohol and Tobacco Consumption in Patients With Head and Neck or Lung Cancer (ALTAK)

Head and Neck Cancer | Lung Cancer

France
AbbVie (prior sponsor, Abbott)

Completed

Study of ABT-767 in Subjects With Breast Cancer 1 and Breast Cancer 2 (BRCA 1 and BRCA 2) Mutations and Solid Tumors or High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Primary Peritoneal Cancer | Fallopian Tube | Solid Tumors (e.g. Breast, Ovarian, Prostate, or Pancreatic) and Ovarian

Netherlands
University of Miami

Terminated

Safety of LEAD Radiotherapy Plus Chemoradiation in Patients With Bulky Stage III Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer | NSCLC

United States
Hoffmann-La Roche

Completed

A Study Examining Long Response in Lung Cancer Patients Treated With Tarceva (Erlotinib)

Non-Small Cell Lung Cancer

Italy
Eisai Inc.
Quintiles, Inc.

Completed

A Study Comparing the Combination of the Best Supportive Care Plus E7080 Versus Best Supportive Care Alone, in Patients With Advanced Lung Cancer or Lung Cancer That Has Spread, Who Have Been Previously Treated, Unsuccessfully, With at Least 2 Different Treatments

Non-Small Cell Lung Cancer

Belgium, Korea, Republic of, Italy, United States, Hungary, United Kingdom, Czechia
Harbin Medical University

Unknown

Nonintervention Study on Peritoneal Metastasis of Stage IV Gastric Cancer

Stage IV Gastric Cancer With Metastasis

China
Maastricht Radiation Oncology

Terminated

Chloroquine as an Anti-autophagic Radiosensitizing Drug in Stage I-III Small Cell Lung Cancer (Chloroquine)

Small Cell Lung Cancer

Netherlands
UNC Lineberger Comprehensive Cancer Center
Celgene Corporation

Terminated

Study of Abraxane and Carboplatin to Treat Small Cell Lung Cancer (NRR)

Small Cell Lung Cancer

United States
University of Michigan Rogel Cancer Center

Completed

Using FDG-PET During Radiation Therapy in Non-Small Cell Lung Cancer (HUM15709)

Non-Small Cell Lung Cancer

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Terminated

Surgery With or Without Internal Radiation Therapy Compared With Stereotactic Body Radiation Therapy in Treating Patients With High-Risk Stage I Non-Small Cell Lung Cancer

Lung Cancer

United States, Canada
Genentech, Inc.

Completed

A Study of PRO95780 in Patients With Previously Untreated, Advanced-Stage Non-Small Cell Lung Cancer (APM4074g)

Non-Small Cell Lung Cancer
GlaxoSmithKline

Terminated

Cancer Immunotherapy GSK1572932A as Adjuvant Therapy for Patients With Tumor-antigen-positive Non-Small Cell Lung Cancer

Lung Cancer, Non-Small Cell

Canada, Italy, Belgium, France, Germany, United Kingdom
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Terminated

Seneca Valley Virus-001 After Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Lung Cancer

United States
OHSU Knight Cancer Institute
The Wayne D. Kuni and Joan E. Kuni Foundation

Completed

Sulforaphane in Treating Patients With Recurrent Prostate Cancer

Recurrent Prostate Cancer | Adenocarcinoma of the Prostate

United States
Genentech, Inc.
Roche Pharma AG

Completed

A Study of Changes in FDG- and FLT-PET Imaging in Patients With Non-Small Cell Lung Cancer Following Treatment With Erlotinib

Non-Small Cell Lung Cancer
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI); Eli Lilly and Company

Completed

Pharmacogenomic & Phase II Study of Gemcitabine and Pemetrexed in Non-Small-Cell Lung Cancer.

Lung Cancer

United States
Novartis Pharmaceuticals

Completed

Study to Assess Efficacy and Safety of Zoledronic Acid and the Value of Markers of Bone Resorption in the Prediction of Bone Metastases and Cancer Treatment-induced Bone Loss (CTIBL) in Patients With Prostate Cancer on Hormone Therapy

Cancer Prostate

Belgium
GlaxoSmithKline

Terminated

A Study Of Oral GW572016 In Advanced Or Metastatic Non-Small Cell Lung Cancer

Lung Cancer, Non-Small Cell

United States, Canada
HealthCare Global Enterprise Ltd.

Unknown

A Novel Modified Tracheo-Esophageal Voice Prosthesis for Total Laryngectomy Patients (TEP)

Laryngeal Cancer | Hypopharynx Cancer

India
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer

Colorectal Cancer | Metastatic Cancer

United States
Celgene Corporation

Completed

Trial of ABI-007 Administered Weekly in Chemotherapy Naive Patients With Advanced Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

United States
Guangdong Association of Clinical Trials

Unknown

Irinotecan Plus Cisplatin Compared With Etoposide Plus Cisplatin for Extensive Stage Small-cell Lung Cancer

Small Cell Lung Cancer

China
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer

Lung Cancer

United States
Hoffmann-La Roche

Completed

An Expanded Access Program of Tarceva (Erlotinib) in Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)

Non-Small Cell Lung Cancer

Italy, Belgium, Israel, Sweden, China, Hong Kong, Australia, Colombia, Romania, Germany, Ireland, Mexico, Korea, Republic of, Taiwan, Turkey, Russian Federation, Czech Republic, Hungary, Netherlands, New Zealand, Peru, Finland, Austria and more
SciClone Pharmaceuticals

Unknown

Thymosin Alpha 1 Plus Maintenance Therapy With the Standard of Care (SoC) in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC), EGFR Wild Type

Non-Small Cell Lung Cancer

Italy
SCRI Development Innovations, LLC
Genentech, Inc.; Pharmacia and Upjohn

Completed

Irinotecan, Carboplatin and Radiation Therapy Followed by Bevacizumab in Limited Stage Small Cell Lung Cancer

Lung Cancer
Peregrine Pharmaceuticals

Withdrawn

Phase 2 Trial of Durvalumab With or Without Bavituximab in Patients With Previously Treated Metastatic Non-small-cell Lung Cancer

Non-Small Cell Lung Cancer
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer

Lung Cancer

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer

Lung Cancer

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Lung Cancer

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Stage IIIA Non-small Cell Lung Cancer

Lung Cancer

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Topotecan, Paclitaxel, and Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer

Lung Cancer

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Hepatic Arterial Infusion With Floxuridine and Systemic Irinotecan After Surgery in Treating Patients With Hepatic (Liver) Metastases From Colorectal Cancer

Colorectal Cancer | Metastatic Cancer

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Sentinel Lymph Node Mapping in Detecting Cancer That Has Spread to Lymph Nodes in Patients With Non-Small Cell Lung Cancer

Lung Cancer

United States
SCRI Development Innovations, LLC
Bayer; OSI Pharmaceuticals

Completed

Sorafenib and Erlotinib or Sorafenib Alone in Advanced Non-Small Cell Lung Cancer Progressing on Erlotinib

Non-Small Cell Lung Cancer

United States
Eastern Hepatobiliary Surgery Hospital

Completed

Research on Surgery and Micro-Invasive Treatment in Recurrent Primary Liver Cancer

Hepatocellular Carcinoma

China
Nasser Hanna, M.D.
Sanofi; Walther Cancer Institute

Completed

Cisplatin/Etoposide/Radiotherapy +/- Consolidation Docetaxel in Advanced Stage III Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

United States
Sun Yat-sen University

Unknown

A Retrospective Study About Treatment Strategy After First/Second Line EGFR-TKI Failure

Non-Small Cell Lung Cancer

China
Intergroupe Francophone de Cancerologie Thoracique

Completed

Bevacizumab in Extensive Small Cell Lung Cancer (CPC)

Small Cell Lung Cancer

France
Indiana University School of Medicine

Terminated

Storage of Bile From Routine Procedures to Study Risk Factors

Cholangiocarcinoma | Biliary Tract Cancer | Gallbladder Cancer

United States
Massachusetts General Hospital
National Cancer Institute (NCI)

Terminated

Proton Radiation Therapy With Cisplatin and Etoposide Followed by Surgery in Stage III Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

United States
Cancer Trials Ireland

Completed

Hypofractionated 3-Dimensional Radiation Therapy in Treating Patients With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer. ICORG 99-09

Lung Cancer

Ireland
Merck Sharp & Dohme LLC

Completed

Clinical Trial of MK0683 in Combination With FDA Approved Cancer Drugs in Patients With Advanced NSCLC (MK0683-058)

Non-Small Cell Lung Cancer
Memorial Sloan Kettering Cancer Center
Schering-Plough

Completed

Phase II Trial of Neoadjuvant Temozolomide in Melanoma Patients With Palpable Stage III or IV Disease Undergoing Complete Surgical Resection

Melanoma | Cancer | Skin Cancer

United States
Memorial Sloan Kettering Cancer Center
Genentech, Inc.

Completed

Intravenous and Intraperitoneal Paclitaxel, Intraperitoneal Cisplatin, and Intravenous Bevacizumab for the Initial Treatment of Optimal Stage II or III Ovarian, Primary Peritoneal, and Fallopian Tube Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary PERITONEUM

United States
Luhua Wang

Unknown

Study of Stereotactic Ablative Radiotherapy (SABR) in Elderly Stage I NSCLC

Non-Small Cell Lung Cancer

China
H. Lee Moffitt Cancer Center and Research Institute
Bristol-Myers Squibb

Completed

Cetuximab Plus Conformal Thoracic Radiotherapy in Patients (Pts) With Inoperable or Unresectable Locally Advanced Non-Small Cell Lung Cancer (LA - NSCLC)

Lung Cancer

United States

3

Subscribe